These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7129911)

  • 21. Superficial bladder cancer epidemiology, diagnosis and management.
    Bulbul MA; Husseini N; Houjaij A
    J Med Liban; 2005; 53(2):107-13. PubMed ID: 16604997
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of urine-based markers for detection and monitoring of bladder cancer.
    Pirtskalaishvili G; Getzenberg RH; Konety BR
    Tech Urol; 1999 Dec; 5(4):179-84. PubMed ID: 10591254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
    Gonzalgo ML; Datar RH; Schoenberg MP; Cote RJ
    Urol Oncol; 2007; 25(3):228-35. PubMed ID: 17483020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening tests for the detection of bladder cancer.
    Betkerur V; Hliang V; Baumgartner G; Rao R; Ablin RJ; Guinan PD
    Allergol Immunopathol (Madr); 1980; 8(3):169-76. PubMed ID: 7405763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer imaging.
    Legg JS
    Radiol Technol; 2008; 79(4):333-46; quiz 347-9. PubMed ID: 18340023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder cancer.
    Barocas DA; Clark PE
    Curr Opin Oncol; 2008 May; 20(3):307-14. PubMed ID: 18391631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS; Feil G; Bichler KH
    Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the prognosis of early cancer of the bladder.
    Wallace DM
    Proc R Soc Med; 1966 Jul; 59(7):609-10. PubMed ID: 5939503
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques.
    Vaskó J
    Scand J Urol Nephrol Suppl; 1994; 160():1-73. PubMed ID: 7529427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sensitive bladder: an atypical presentation of cancer in a U.S. Army pilot.
    Carter RM; Mansfield JT
    Aviat Space Environ Med; 1999 Apr; 70(4):335-7. PubMed ID: 10223269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic delay and prognosis in invasive bladder cancer.
    Liedberg F; Anderson H; Månsson A; Månsson W
    Scand J Urol Nephrol; 2003; 37(5):396-400. PubMed ID: 14594688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
    Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
    Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of multiparameter flow cytometry in the detection and evaluation of human bladder tumors].
    Fradet Y; Tardif M; Parent-Vaugeois C
    Union Med Can; 1985 Sep; 114(9):778-80. PubMed ID: 4060349
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer.
    Abbate I; D'Introno A; Cardo G; Marano A; Addabbo L; Musci MD; Pagliarulo A; Correale M; Quaranta M
    Anticancer Res; 1998; 18(5B):3803-5. PubMed ID: 9854500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine based markers of urological malignancy.
    Konety BR; Getzenberg RH
    J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of bladder carcinoma].
    Mantur M; Jakubowska I; Kemona H
    Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.